Global Optical Genome Mapping Market, By Product (Instruments, Consumables and Reagents, Software, Services), By Application (Structural Variant Detection, Genome Assembly, Microbial Strain Typing, Others), By End User (Biotechnology and Pharmaceutical Companies, Clinical Laboratories, Academic research institutes , Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published In : Jan 2024

Code : CMI6583

Pages :162

Formats :

Excel and PDF

Industry : Biotechnology

Market News

Global Optical Genome Mapping Market- Recent Developments

Product and Technology Launch

On June 29, 203, Bionano Genomics, Inc., a genome analysis company, announced the Stratys system for high throughput optical genome mapping (OGM) and VIA software for the visualization, interpretation, and reporting of genome analysis for OGM, microarrays, and next-generation sequencing (NGS) data in one integrated software platform.
On January 23, 2023, Bionano Genomics, Inc. announced the launch of multiple new products and advancements for its optical genome mapping (OGM) workflow that offers enhanced robustness in sample preparation, decreased turnaround time for DNA labeling and imaging, and improvements in throughput and quality metrics. The new versions of company’s sample prep kits, chips, and instrument software address customer feedback and can improve the performance in routine higher volume genome analysis applications.
In June 2022, Arima Genomics, a biotechnology company, introduced two new product lines, the Arima-HiC+ FFPE kit, which allows scientists to use this technology to identify structural variants in their 3D genomic data. Researchers will learn more about the effects of variations on gene and cellular function by fusing structural variant detection with 3D genome orientation data.

Business Development Activities by the Market Players

In November 2022, Bionano Genomics, Inc. announced that it had entered into a definitive agreement to acquire Purigen Biosystems, Inc., a company that develops and commercializes automated nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology, which was licensed exclusively from Stanford and developed by Purigen Biosystems, a biotechnology company. The transaction was expected to accelerate the adoption of OGM due to anticipated improvements in its ultra-high molecular weight (UHMW) DNA sample preparation workflow.
In October 2021, Bionano Genomics, Inc. announced its US$100 million acquisition of BioDiscovery Inc., a software company specializing in genomics data. This acquisition grants it access to BioDiscovery Inc.’s Nx Clinical software, which the company plans to integrate into its optical genome mapping (OGM) software.